Effects of a lipase inhibitor (Orlistat) on cholecystokinin and appetite in response to a high-fat meal
Open Access
- 24 November 2003
- journal article
- clinical trial
- Published by Springer Nature in International Journal of Obesity
- Vol. 27 (12) , 1479-1485
Abstract
OBJECTIVE: To examine the short-term effects of a lipase inhibitor (Orlistat) on physiological and behavioural measures of appetite in response to a high-fat meal. DESIGN: Randomised, single blind, placebo-controlled, crossover trial. SUBJECTS: A total of 19 healthy nonobese male subjects. PROCEDURES: After an overnight fast, subjects ingested a test meal of 2940 kJ (60% fat, 30% CHO, 10% protein) with Orlistat (120 mg) or a placebo, separated by 2 weeks. Appetite, as assessed by a standard line scale, and plasma cholecystokinin (CCK) concentrations were measured prior to and every hour after the test meal for 4 h. Thereafter, subjects ingested a quantified, but self-selected portion of a standardised lunch (15% protein, 37% fat and 45% CHO), before completing a final line scale questionnaire. RESULTS: The CCK response to the test meal was negatively correlated with BMI in both the Orlistat and placebo trials (R=−0.69 and −0.65, Pvs 7.36±3.94 pM min, for Orlistat and placebo, P=0.193). Similarly, the line scale measures of appetite and subsequent intake (520±205 vs 554±197 g, P=0.48) were not different between the trials. CONCLUSION: Orlistat administration did not alter short-term physiological or behavioural measures of satiety in response to a high-fat meal in healthy, nonobese subjects. The CCK response to a test meal may be partly determined by BMI.Keywords
This publication has 21 references indexed in Scilit:
- The effect of cholecystokinin in controlling appetite and food intake in humansPeptides, 2001
- Comparative Evaluation of Fecal Fat Excretion Induced by Orlistat and ChitosanObesity Research, 2001
- Oral, gastric and intestinal influences on the control of appetite and feeding in humansAppetite, 2001
- Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humansGastroenterology, 2001
- Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitorGut, 2000
- Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studiesInternational Journal of Obesity, 2000
- Cholecystokinin is a Satiety Hormone in Humans at Physiological Post-Prandial Plasma ConcentrationsClinical Science, 1995
- Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteersClinical Pharmacology & Therapeutics, 1994
- Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.Journal of Clinical Investigation, 1985
- Nutrients and behaviour: Research strategies for the investigation of taste characteristics, food preferences, hunger sensations and eating patterns in manJournal of Psychiatric Research, 1982